Steven P. James
Steven P. James is a businessperson who has been at the head of 5 different companies. He is Chairman of Antiva Biosciences, Inc., Executive Chairman, President & CEO at Pionyr Immunotherapeutics, Inc. and Chairman of Soteria Therapeutics, Inc. Steven P. James is also on the board of Allakos, Inc., Middlebridge School, Ventus Therapeutics, Inc. and Ventus Therapeutics U.S., Inc.
He previously occupied the position of Principal at Eli Lilly & Co., VP-Business Development & General Manager at Landec Corp., Vice President-Business Development of Ionis Pharmaceuticals, Inc., Senior Vice President-Commercial Operations at Exelixis, Inc., President & Chief Executive Officer of KAI Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Labrys Biologics, Inc., Chief Business Officer at Sunesis Pharmaceuticals, Inc. and Principal at California Biotechnology, Inc.
He received an undergraduate degree from Brown University and a graduate degree from Kellogg School of Management.
|09/28/2021||4,000||Disposition at $108.12 per share.||432,480|
|09/28/2021||4,000||Derivative/Non-derivative trans. at $0.52 per share.||2,080|